Patents for A61K 49 - Preparations for testing in vivo (35,376)
05/2013
05/08/2013CN103083690A Capsule for gastrointestinal color ultrasound contrast
05/08/2013CN103083689A Cross-blood-brain-barrier targeting multimodal nano-medicine used in brain tumor diagnosis
05/08/2013CN103083688A Ferrate magnetic nanocomposite with core-shell structure, preparation method and application thereof
05/08/2013CN103083687A Application of silver and platinum nano-cluster in tumor targeted imaging
05/08/2013CN103083133A Fundus disease laser photo-thermal treatment system based on gold nanorods
05/08/2013CN102492686B Kctd10 gene knock-out mouse model, construction method and application thereof
05/08/2013CN102228702B Method for preparing dendrimer mediated gold-silver alloy nanoparticles
05/08/2013CN102174170B Polyurethane material and application thereof as X-ray developing material and magnetic material
05/08/2013CN101616692B Polychromatic, diversely-sized particles for angiography
05/07/2013US8435496 Nanoparticle clusters and methods for forming same
05/07/2013US8435495 Characterization of granulocytic Ehrlichia and methods of use
05/07/2013US8435494 Mesothelin antibody protein fusions and methods of use
05/07/2013CA2564197C Activatable particles, preparations and uses
05/07/2013CA2383982C Transgenic animal expressing a multiple mutated form of presenilin 1
05/02/2013WO2013062202A1 Mri contrast agent coated with amphoteric ion
05/02/2013WO2013061818A1 Novel peptide complex and hybrid complex thereof, and use of said hybrid complex
05/02/2013WO2013060919A1 Controlled synthesis of polyglutamates with low polydispersity and versatile architectures
05/02/2013WO2013036869A3 Compositions, methods, and systems for the synthesis and use of imaging agents
05/02/2013WO2013036543A3 Molecular imaging of cancer cells in vivo
05/02/2013WO2013020040A3 Radiated cancer cells as a vehicle for cancer nanotherapy
05/02/2013US20130108554 Contrast agents
05/02/2013US20130108553 Metal Mixes For Use In Epicutaneous Patch Test
05/02/2013US20130108552 Near-ir indocyanine green doped multimodal silica nanoparticles and methods for making the same
05/02/2013US20130108550 Bioabsorbable Co-Filler for Cerebrovascular Aneurysms
05/02/2013US20130108546 Humanized Antibodies That Recognize Alpha-Synuclein
05/02/2013CA2853705A1 Free psa antibodies as diagnostics, prognostics and therapeutics for prostate cancer
05/01/2013EP2585611A2 Use of bacterial beta-lactamase for in vitro diagnostics and in vivo imaging, diagnostics and therapeutics
05/01/2013EP2585116A2 Modeling of pharmaceutical propagation and parameter generation for injection protocols
05/01/2013CN103079642A Nanoparticle-guided radiotherapy
05/01/2013CN103079599A Targeted gas-filled microvesicles
05/01/2013CN103079598A Single isomeric conjugates of rhodamine dyes
05/01/2013CN103079592A Method for treating and diagnosing cancer by using cell-derived microvesicles
05/01/2013CN101321750B Multimeric magnetic resonance contrast agents
05/01/2013CN101019028B Compounds and methods for combined optical-ultrasound imaging
04/2013
04/30/2013US8431723 Radicals and their use as paramagnetic agents in a DNP process
04/30/2013US8431118 Anti-herpes simplex virus antibodies and methods of use thereof
04/30/2013US8431110 Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators
04/30/2013CA2730627C Human and mouse targeting peptides identified by phage display
04/30/2013CA2567064C Optical sensor for in vivo detection of analyte
04/25/2013WO2013059437A1 Inhibitors of arginase and their therapeutic applications
04/25/2013WO2013058774A1 Compositions comprising ascorbic acid and an imaging agent and related methods
04/25/2013WO2013058482A2 Multi-functional nucleic acid-based anti-cancer drug capable of targeting and therapy, method for preparing same and anti-cancer composition comprising same
04/25/2013WO2013057933A1 Contrast agent, contrast agent kit, and method for administering contrast agent
04/25/2013WO2012174285A3 Inhibitor probes for imaging sodium-glucose cotransporters in health and disease
04/25/2013WO2012173933A3 Activatable nanoprobes for intracellular drug delivery
04/25/2013WO2012037928A3 Compounds for the diagnosis of neurodegenerative disorders on the olfactory epithelium
04/25/2013US20130102898 Liposome including elastin-like polypeptides and use thereof
04/25/2013US20130102897 Modeling of pharmaceutical propagation
04/25/2013US20130101522 Ultrasound Contrast Agents And Process For The Preparation Thereof
04/25/2013US20130101520 Ultrasound contrast agents and methods of making and using them
04/25/2013US20130101519 Diagnostic Method for Atherosclerosis
04/25/2013US20130101518 Method and apparatus for kidney function analysis
04/25/2013US20130101515 Method of selecting antioxidants for use in topically applied compositions
04/25/2013US20130101513 Method of using near infrared fluorescent dyes for imaging and targeting cancers
04/25/2013US20130101512 Crosslinked polynucleotide structure
04/25/2013US20130101511 In vivo imaging of enzymatic activity
04/25/2013US20130101506 Compositions comprising nucleic acid aptamers
04/25/2013CA2852395A1 Compositions comprising ascorbic acid and an imaging agent and related methods
04/24/2013EP2583981A2 Antibodies and related molecules that bind to PSCA proteins
04/24/2013EP2582400A2 Tuned multifunctional magnetic nanoparticles for biomedicine
04/24/2013CN103069274A Method for quantitative measurement of gastric acidity using 13c carbonate salt
04/24/2013CN103068830A Inhibitors of arginase and their therapeutic applications
04/24/2013CN103055329A Manufacturing method of targeted magnetic nanometer probe for early diagnosis of atherosclerosis vulnerable plaques
04/24/2013CN103055328A Degradable dendritic macromolecule magnetic resonance contrast agent and preparation method thereof
04/24/2013CN103055327A Bifunctional contrast agent for fluorescence imaging and magnetic resonance imaging
04/24/2013CN103055314A 雌激素的应用 Application of estrogen
04/24/2013CN103055312A Application of ferroferric oxide as photo-thermal sensitive material
04/24/2013CN102125699B Fe3O4/TiO2 composite nano-particles as well as preparation method and application thereof in magnetic resonance imaging contrast medium
04/23/2013US8425880 Metal-containing materials for treatment of bacterial conditions
04/23/2013US8425879 Metalloporphyrin derivatives, nanoparticles comprising the same, and use thereof for photodynamic therapy
04/23/2013US8425878 Plasma membrane biomarkers preferentially expressed in pancreatic beta cells useful in imaging or targeting beta cells
04/23/2013US8425877 Method for diagnosis of systemic sclerosis involving an anti-AT1-receptor antibody
04/23/2013CA2567429C Restless legs syndrome/periodic appendicular dyskinesia model animal
04/23/2013CA2562170C 5-aminolevulinic acid salt, process for producing the same and use thereof
04/23/2013CA2504818C Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same
04/18/2013WO2013056132A2 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery including transdermal delivery of cargo and methods thereof
04/18/2013WO2013056092A1 Multi-component nanochains
04/18/2013WO2013055791A1 Polymeric nanoparticles for ultrasound imaging and therapy
04/18/2013WO2013054126A2 Nanocolloids for local temperature monitoring
04/18/2013WO2013053927A1 Photodynamic diagnosis of abnormalities of the epithelial lining of the oesophagus with the means of a 5-ala ester
04/18/2013WO2013053839A1 Process for the preparation of hyperpolarized derivatives for use in mri analysis
04/18/2013WO2013053042A1 Porphyrin-phospholipid conjugate microbubbles and their use as contrast agents.
04/18/2013US20130096420 Process For Preparing Hyperpolarized Substrates And Method For MRI
04/18/2013US20130095041 Skin Profiling and Its Use in Testing Cosmetics
04/18/2013US20130095040 Dye compositions and dye syntheses
04/18/2013US20130095039 Nucleic acid-mediated shape control of nanoparticles
04/18/2013US20130095038 Particles, and photoacoustic imaging contrast agent and sln contrast agent including the particles
04/18/2013US20130095036 Methods and compositions for diagnosis of iga-and igm-mediated kidney diseases
04/18/2013CA2852099A1 Meditopes and meditope-binding antibodies and uses thereof
04/18/2013CA2852064A1 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery including transdermal delivery of cargo and methods thereof
04/18/2013CA2851614A1 Compositions useful in treating nephropathy and methods for preparation of same
04/18/2013CA2849538A1 Porphyrin microbubbles
04/17/2013CN103045606A K14-VEGF transgenic mouse model, and construction method and application of model
04/17/2013CN103043724A Oxidized graphene/MnFe2O4 nanometer hybrid material and preparation method thereof
04/17/2013CN103041410A Contrast powder for gastrointestinal ultrasonic diagnosis
04/17/2013CN103041409A Preparation method of pH and thermal dual-sensitive lipidosome loaded with magnetic carbon quantum dots on internal water phase
04/17/2013CN103041408A Core-shell type nano-contrast agent, preparation method and application thereof
04/17/2013CN103041407A Core-shell type nano-contrast agent, preparation method and application thereof
04/17/2013CN103041406A Method for preparing diagnosis and treatment-cooperated nano particles release system by template method
04/17/2013CN103041405A Diagnosis-treatment integrative medicine carrying polymer and preparation method thereof
1 ... 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 ... 354